NCT01636505View on ClinicalTrials.gov

The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol

PHASE3UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

September 30, 2013

Conditions
Embryo's Genetic and Chromosomal Quality
Interventions
DRUG

ghrh antagonist (cetrotide/orgalutran)

cetrotide/orgalutran 0.25 mg

DRUG

gnrh agonist (suprefact)

suprefact 5.5 ml

Trial Locations (1)

00148

European Hospital, Rome

Sponsors

Lead Sponsor

European Hospital
All Listed Sponsors
lead

European Hospital

OTHER